)
Excellent data is the key to precision oncology.
Take a look into the world’s most comprehensive high‑quality multi‑omics cancer database
Unique Database Multi-omics data of unparalleled quality
An in-depth multi-omics analysis of matched tumor and normal tissue, collected and processed in a standardized way, is the foundation of Indivumed’s R&D programs. Following this approach of global clinical collaboration over decades, we can now draw on a proprietary database that reflects the molecular reality of cancer at a level never seen before. This is the key to our cutting-edge data analytics for innovative target and drug discovery.
In-depth data that reflects the biological reality of cancer
Clinical data
)
- Up to 320 data points per patient
- Up to ten years of follow-up data
Multi-omics processing
)
On both tumor and normal tissue
- Whole genomics
- Whole transcriptomics
- Small RNAs
- Total proteomics
- Phosphoproteomics
- More depending on the project
Digital pathology
)
- H&E stain scans
- FFPE sections for IHC
Diverse cancer types
)
- CRC, NLCLC, Breast Cancer, and others
- Samples collected globally (Asia, Europe, Americas)
:format(webp))
There was no data that matched our ambitions. So, we created our own.
We extract multi-omics information from matched tumor and normal tissue samples using next-generation sequencing and mass spectrometry technologies. However, it is not the technology that makes our data unique, but the exceptional quality of our samples. The key innovation on which our excellent data quality is based today is our rapid SOP-guided tissue collection and conservation process.
)
Ten minutes make all the difference.
It takes years for novel drugs to reach the market, however, the first ten minutes in the collection, processing, and conservation process are crucial. Research shows that minimizing ischemia time has a major impact on the integrity of tissue samples and is very important to preserve the expression of otherwise undetectable therapeutic targets.
Comprehensive data
“An incomplete picture of cancer biology leads researchers to overlook potentially important targets or waste time and money on false leads.”
)
Tissue collection SOPs Special surgery procedures to protect sample integrity
While surgeons focus on removing the tumor and pathologists on subsequent tissue diagnostics, there is routinely no attention to the proper conservation of patient material that could be used for further biomedical research. That is why we, together with surgeons and oncologists from around global clinical network, have developed over the years a series of special standard operating procedures (SOPs) for the collection and preservation of tissue samples. These procedures, including keeping cold ischemia times to under ten minutes, ensure pre-analytically controlled specimens with a very high sample integrity.
)